openPR Logo
Press release

Pharyngitis Market Future Forecast Indicates Impressive Growth Rate

01-22-2021 07:19 AM CET | Health & Medicine

Press release from: Fact.MR

Pharyngitis Market

Pharyngitis Market

Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=361

As per the report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register 3.4% CAGR during the forecast period 2017-2026. The global pharyngitis market is also estimated to reach US$ 1,679.0 million revenue by the end of 2026. Pharyngitis is the most common problem among people. It is mostly caused due to other illness such as flu, cold, or mononucleosis it results in sore throat. Most of the health providers diagnose pharyngitis with the help of rapid strep test. Medicines are given by doctor only after determining whether the infection is viral or bacterial. Hence, manufacturers of drugs are conducting research to develop more effective drugs to treat pharyngitis. Below are few insights on how the global pharyngitis market will perform in the coming years.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=361

5 Forecast Highlights on Global Pharyngitis Market

• Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
• North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.
• Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
• Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
• Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

Get Full Access of the Report @ https://www.factmr.com/checkout/361/S

The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.

Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharyngitis Market Future Forecast Indicates Impressive Growth Rate here

News-ID: 2229438 • Views:

More Releases from Fact.MR

Used Construction Equipment Market to Surpass US$ 234 Billion, Expanding at 6.9% CAGR by 2035: Fact.MR Analysis
Used Construction Equipment Market to Surpass US$ 234 Billion, Expanding at 6.9% …
The global used construction equipment market is expected to experience substantial growth over the coming decade as infrastructure expansion, cost-conscious procurement, and equipment lifecycle optimization become critical for construction companies worldwide. As of 2025, the market is valued at USD 120 billion and is projected to reach USD 234 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.9% during the forecast period. Market growth is being driven
Mobile Robot Platform Market Growth to Reach US$ 9,998.5 Million at a CAGR of 12.7% by 2035 | Fact.MR
Mobile Robot Platform Market Growth to Reach US$ 9,998.5 Million at a CAGR of 12 …
The global mobile robot platform market is forecast to reach USD 9,998.5 million by 2035, up from USD 3,024.8 million in 2025. During the forecast period, the industry is projected to register at a CAGR of 12.7%. Rising automation across industries and labor shortages are accelerating the adoption of mobile robot platforms. Technological advancements in AI, sensors, and connectivity are enabling smarter, autonomous navigation and operations. For More Insights into the Market,
Industrial Visioneers Market Size Expected to Hit US$ 22.9 Billion by 2035, Exhibiting 7.3% CAGR: Fact.MR Analysis
Industrial Visioneers Market Size Expected to Hit US$ 22.9 Billion by 2035, Exhi …
The global industrial visioneers market is expected to reach USD 22.9 billion by 2035, up from USD 11.3 billion in 2025. During the forecast period (2025 - 2035), the industry is projected to expand at a CAGR of 7.3%. The market of the industrial visioneers is of pivotal significance since the manufacturing industries take several steps towards automation and precision-oriented quality control. The rapidly growing demand for AI-enabled vision systems in
Edge Controllers Market Size Worth US$ 20,484 Million with 19.1% CAGR by 2035: Fact.MR Report
Edge Controllers Market Size Worth US$ 20,484 Million with 19.1% CAGR by 2035: F …
The global edge controllers market is expected to reach USD 20,484 million by 2035, up from USD 3,567 million in 2025. During the forecast period (2025 to 2035), the industry is projected to expand at a CAGR of 19.1%. The edge controllers market is vital in accelerating real-time data processing across industries. Smart manufacturing, energy management and autonomous systems where urgent prediction is crucial are in demand. Fueled by the integration

All 5 Releases


More Releases for Pharyngitis

Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Is the Expected CAGR for the Pharyngitis Treatment Market Through 2025? The market for pharyngitis treatment has seen consistent growth over the past few years. The predicted expansion is from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
The Pharyngitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Pharyngitis Treatment Market Size and Projected Growth Rate? In recent times, there has been a consistent increase in the size of the pharyngitis treatment market. It is projected to expand from $2.27
Revolutionizing Relief: Contemporary Approaches to Pharyngitis Treatment
Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry. The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis Therapeutics Market Dynamics According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious